Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group

被引：0
|
作者：
Stupp, R
Mason, WP
Van Den Bent, MJ
Weller, M
Fisher, B
Taphoorn, M
Brandes, AA
Cairncross, G
Lacombe, D
Mirimanoff, RO
机构：
[1] CHU Vaudois, Univ Hosp, CH-1011 Lausanne, Switzerland
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Univ Rotterdam Hosp, Rotterdam Canc Ctr, Rotterdam, Netherlands
[4] Univ Tubingen, Sch Med, D-72074 Tubingen, Germany
[5] Univ Western Ontario, London, ON N6A 3K7, Canada
[6] Univ Utrecht, Med Ctr, NL-3508 TC Utrecht, Netherlands
[7] Azienda Osped Univ, Osped Busonera, Padua, Italy
[8] Univ Calgary, Calgary, AB T2N 1N4, Canada
[9] Eortc Data Ctr, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：1S / 1S
页数：1
相关论文
共 50 条
  • [1] Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group
    Mirimanoff, R
    Mason, W
    Kortmann, R
    Van den Bent, M
    Fisher, B
    Taphoorn, M
    Reni, M
    Curschmann, J
    Villa, S
    Cairncross, G
    Gorlia, T
    Stupp, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S162
  • [2] Is long-term survival in Glioblastoma possible? Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant Temozolomide (TMZ) versus RT alone
    Mirimanoffr, R.
    Mason, W.
    Van den Bent, M.
    Kortmann, R.
    Taphoorn, M.
    Brandes, A.
    Villa, S.
    Cairncrosss, G.
    Gorlia, T.
    Stupp, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S2 - S2
  • [3] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
  • [4] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Clarke, Jennifer
    Abrey, Lauren
    Karimi, Sasan
    Lassman, Andrew
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
  • [5] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Clarke, J. L.
    Abrey, L. E.
    Karimi, S.
    Lassman, A. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    [J]. NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [9] RADIOTHERAPY (RT) WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) IN GLIOBLASTOMA MULTIFORME (GBM) - LONG TERM RESULTS FROM A SINGLE UNITED KINGDOM CENTRE
    Haylock, B.
    Husband, D.
    Shenoy, A.
    Wong, H.
    Brodbelt, A.
    Walker, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S34 - S35
  • [10] Mature results of a phase I/IIA trial of the integrin inhibitor cilengitide (EMD121974) added to standard concomitant and adjuvant temozolomide and radiotherapy (TMZ/RT) for newly diagnosed glioblastoma (GBM)
    Stupp, Roger
    Goldbrunner, Roland
    Neyns, Bart
    Schlegel, Uwe
    Clement, Paul
    Grabenbauer, Gerhard
    Hegi, Monika
    Nippgen, Johannes
    Picard, Martin
    Weller, Michael
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 517 - 517
12345